Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T16:12:21.381Z.
Calculation as of: 2026-10-06T16:12:21.381Z.
Quote observation: 2026-10-06T16:10:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 87a3ef4e55b06d985fb23947e4d9ae6563d80488a3a61227015f8099389db825
EARNINGS YIELD
N/A
Market Cap
$809925.00
Earnings Yield
N/A
TTM Avg
233.12%
3Y Avg
232.94%
5Y Avg
366.47%
Market Cap
$816286.00
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$858810.00
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$859931.00
Earnings Yield
N/A
TTM Avg
30990441.81%
3Y Avg
30990441.81%
5Y Avg
30990441.81%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HCW Biologics Inc. (HCWB) | $563178.00 | N/A | N/A | N/A | N/A |
| CDT Equity Inc. (CDT)vs › | $669300.00 | N/A | N/A | N/A | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | N/A | N/A | N/A | N/A |
| Ridgetech, Inc. (RDGT)vs › | $809925.00 | N/A | 233.12% | 232.94% | 366.47% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $816286.00 | N/A | N/A | N/A | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $845829.00 | N/A | N/A | N/A | N/A |
| Sunshine Biopharma, Inc. (SBFM)vs › | $858810.00 | N/A | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $859931.00 | N/A | 30990441.81% | 30990441.81% | 30990441.81% |
| GlucoTrack, Inc. (GCTK)vs › | $869976.00 | N/A | N/A | N/A | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $94810.00 | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
